Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Cash & Current Investments: 2022-2025

Historic Cash & Current Investments for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $2.8 million.

  • Addex Therapeutics' Cash & Current Investments rose 1506.30% to $2.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $13.6 million, marking a year-over-year increase of 100.00%. This contributed to the annual value of $3.8 million for FY2024, which is 11.59% down from last year.
  • As of Q2 2025, Addex Therapeutics' Cash & Current Investments stood at $2.8 million, which was down 11.51% from $3.2 million recorded in Q1 2025.
  • In the past 5 years, Addex Therapeutics' Cash & Current Investments ranged from a high of $7,958.2 billion in Q2 2023 and a low of -$2,320.2 billion during Q3 2023.
  • In the last 3 years, Addex Therapeutics' Cash & Current Investments had a median value of $3.5 million in 2024 and averaged $563.8 billion.
  • Within the past 5 years, the most significant YoY rise in Addex Therapeutics' Cash & Current Investments was 86,936,095.07% (2023), while the steepest drop was 22,236,379.56% (2023).
  • Addex Therapeutics' Cash & Current Investments (Quarterly) stood at $7.2 million in 2022, then crashed by 39.67% to $4.4 million in 2023, then declined by 12.31% to $3.8 million in 2024, then soared by 1,506.30% to $2.8 million in 2025.
  • Its Cash & Current Investments was $2.8 million in Q2 2025, compared to $3.2 million in Q1 2025 and $3.8 million in Q4 2024.